Commentary by Arthur Sinkman MD, NYU Department of Psychiatry
Three years ago the FDA began requiring that all selective serotonin reuptake inhibitors (SSRIs) carry a black-box warning stating that their use in children and adolescents is …
Commentary by Arthur Sinkman MD, NYU Department of Psychiatry
Three years ago the FDA began requiring that all selective serotonin reuptake inhibitors (SSRIs) carry a black-box warning stating that their use in children and adolescents is …
Commentary by Alana Choy-Shan MD, NYU Chief Resident
The highly anticipated results of the ENHANCE trial will likely be presented at the American College of Cardiology meeting in March, but the preliminary results already have …
Commentary by David Steckman MD, PGY-2 and William Slater MD, Associate Professor of Medicine, Division of Cardiology
Case: A 42 year-old man presents to clinic for routine follow-up. He is found …
Is there evidence to support the use of Lantus® (human insulin analog glargine) administered Q12h in Type 1 Diabetes?
Commentary by Kathy Lee, Pharmacy ResidentÂ
The goal of diabetes management is to reduce …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to our final case of our special diabetes series intended to highlight …
Commentary by Robert Leonard PharmD, Pharmacy Resident New York Harbor Healthcare System
On November 20, 2007 the FDA announced mounting evidence linking varenicline (Chantix®) therapy for smoking cessation with suicidal ideation and erratic and …
Commentary by Neal Steigbigel MD, Professor of Medicine (Infectious Diseases/Immunology)
Methicillin resistant Staphylococcus aureus (MRSA) was a hot topic at this year’s IDSA meeting. The CA (community-acquired)-MRSA strains are spreading rapidly …
Commentary by Shrujal Baxi MD, Ethics Section Editor, and Joseph Lowy MD, Medical Director, Palliative Care Service at NYU Hospital
Mrs. Pleasant is an 85 year old woman brought into the ER by her …